The cost of new oral anti-diabetic drugs in Canada and internationally = Coût des nouveaux médicaments antidiabétiques au Canada et à l’étranger. : H82-44/2018-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.872400&sl=0
Department/Agency | Canada. Patented Medicine Prices Review Board. |
---|---|
Title | The cost of new oral anti-diabetic drugs in Canada and internationally = Coût des nouveaux médicaments antidiabétiques au Canada et à l’étranger. |
Variant title | Coût des nouveaux médicaments antidiabétiques au Canada et à l’étranger |
Publication type | Monograph |
Language | Bilingual-[English | French] |
Format | Electronic |
Electronic document | |
Note(s) | "NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada." Includes bibliographical references. Issued also in HTML format. Text in English and in French. |
Publishing information | [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2018] |
Description | 1 online resource (1 page) : coloured graphs |
Catalogue number |
|
Subject terms | Prescription drugs Diabetes |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: